pharmaphorum

NOVEMBER 30, 2016

Join us and PHOENIX group as we delve into the concept of current launch excellence and the role of patient insights in overcoming the multiple challenges the industry currently faces. Key topics to be discussed include: – The challenges of launching a product in Europe – How pharma can improve its understanding of the process through the use of business intelligence – How insights from new data can be applied to the process of launch excellence – The role of real-world data in launch strategy –

Production 52

Production 52

Placebo Control

NOVEMBER 21, 2016

On this date 349 years ago, Samuel Pepys relates in his famous diary a remarkable story about an upcoming medical experiment. As far as I can tell, this is the first written description of a paid research subject. According to his account , the man (who he describes as “a little frantic”) was to be paid to undergo a blood transfusion from a sheep. It was hypothesized that the blood of this calm and docile animal would help to calm the man.

Research 40

Research Clinical Trials Clinical Trials Trials 40

pharmaphorum

NOVEMBER 22, 2016

Working with QuintilesIMS, we present a digital debate which will offer modellling-based insights into the future of hepatitis C treatment.

Marketing 52

Marketing 52

pharmaphorum

NOVEMBER 16, 2016

Over the past 20 years, behavioural economics has identified factors that influence and determine how people behave, including alternative decision-making pathways and many cognitive biases and heuristics. Taking account of these helps to build a clear view of how healthcare customers think and behave in relation to your product in the real world. This short masterclass explores ‘quantitative demand assessment research’ – what it is and how insights from behavioural economics can improve the app

Research 52

Research Marketing Production 52

Speaker: Simran Kaur, Co-founder & CEO at Tattva Health Inc.

AI is transforming clinical trials—accelerating drug discovery, optimizing patient recruitment, and improving data analysis. But its impact goes far beyond research. As AI-driven innovation reshapes the clinical trial process, it’s also influencing broader healthcare trends, from personalized medicine to patient outcomes. Join this new webinar featuring Simran Kaur for an insightful discussion on what all of this means for the future of healthcare!

Clinical Trials

pharmaphorum

NOVEMBER 2, 2016

Senior level expert panel debate on the likely impacts of a hard v soft Brexit for life sciences companies in Britain.

Life Science 40

Life Science 40